GeneDx Holdings WGS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $102.25M-15.5% | $120.99M+3.6% | $116.74M+13.7% | $102.69M+17.9% | $87.12M-8.9% | ||
| $34.04M-7.3% | $36.72M+14.0% | $32.22M+1.3% | $31.79M+11.0% | $28.64M-2.7% | ||
| $68.21M-19.1% | $84.27M-0.3% | $84.53M+19.2% | $70.9M+21.2% | $58.48M-11.7% | ||
| 66.7%-2.9pp | 69.6%-2.8pp | 72.4%+3.4pp | 69%+1.9pp | 67.1%-2.1pp | ||
| $19.8M-19.3% | $24.54M+23.8% | $19.83M+31.5% | $15.08M+19.9% | $12.58M+8.5% | ||
| $74.59M— | —— | —— | —— | $50.45M— | ||
| -$717K-37.9% | -$520K+7.5% | -$562K+31.2% | -$817K-27.7% | -$640K+8.3% | ||
| -$4.95M-23.9% | -$4M+3.4% | -$4.14M-358% | $1.6M+205% | -$1.53M+54.9% | ||
| -$63.32M-258% | -$17.67M-131% | -$7.64M-171% | $10.81M+266% | -$6.53M— | ||
| -61.9%-47.3pp | -14.6%-8.1pp | -6.5%-17.1pp | 10.5%+18.0pp | -7.5%— | ||
| -$50.66M-589% | -$7.35M-328% | $3.22M-78.7% | $15.15M+1,244% | $1.13M— | ||
| -49.5%-43.5pp | -6.1%-8.8pp | 2.8%-12.0pp | 14.8%+13.5pp | 1.3%— | ||
| -$57.47M-304% | -$14.24M-338% | -$3.25M-136% | $8.96M+297% | -$4.55M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are GeneDx Holdings's profit margins?
- Gross margin is 69.6% and operating margin is -14.9%, with a -17.6% net margin.
- Where does GeneDx Holdings's income statement data come from?
- Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.